NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy

NCT02319824 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

BIOLOGICAL: Autologous NY-ESO-1-specific CD8-positive T Lymphocytes
OTHER: Laboratory Biomarker Analysis
RADIATION: Palliative Radiation Therapy

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]